The Effect of Statins on Ocular Disorders: A Systematic Review of Randomized Controlled Trials.
Charoula LymperopoulouStylianos A KandarakisIsmini TzanakiIoanna MylonaTheodoros XanthosAris P AgouridisPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
Based on our findings, we believe that statins have no cataractogenic effect. There are indications that statins may have a protective role against cataract formation, AMD, diabetic retinopathy progression, and non-infectious uveitis. However, our results were insufficient for any robust conclusion. Future RCTs, with large sample sizes, on the current topic are therefore recommended to provide more solid evidence.